Bristol Myers Squibb stock gains 0.55 percent after-hours to EUR 53.19
Published on 10/07/2026 at 20:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
After-hours trading
At 8:48 p.m. CEST on October 7, 2026, Bristol Myers Squibb stock was in after-hours trading at EUR 53.19, up 0.55 percent versus the prior close at Lang & Schwarz of EUR 52.90 on October 6, 2026. The quote showed a bid of EUR 53.09 and an ask of EUR 53.29. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
Recent company update
Bristol Myers Squibb had announced on September 30, 2026, that the U.S. Food and Drug Administration approved an expanded CAMZYOS indication for symptomatic obstructive hypertrophic cardiomyopathy in adults and pediatric patients weighing at least 30 kilograms, according to the company’s Bristol Myers Squibb release.
Third-quarter results scheduled
The company said in a September 18, 2026, release that it will announce third-quarter 2026 results on October 29, 2026. Bristol Myers Squibb said executives will review the results with the investment community during a conference call beginning at 8:00 a.m. Eastern Time. The company also said materials related to the call would be available through its Investor Relations website before the event, according to the company announcement.
